MUFG Americas’s Haemonetics HAE Stock Holding History

MUFG Americas’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-40	Closed	-$2K	–	1188
2015 Q2	$2K	Buy	+40	New	+$1.69K	﹤0.01%	1082
2015 Q1	–	Sell	-545	Closed	-$20K	–	1181
2014 Q4	$20K	Hold	545	–	–	﹤0.01%	817
2014 Q3	$19K	Hold	545	–	–	﹤0.01%	827
2014 Q2	$19K	Hold	545	–	–	﹤0.01%	851
2014 Q1	$18K	Buy	+545	New	+$20.8K	﹤0.01%	832
2013 Q3	–	Sell	-37,664	Closed	-$1.56M	–	1287
2013 Q2	$1.56M	Buy	+37,664	New	+$1.52M	0.03%	434

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MUFG Americas's HAE Position: Q3 2015 in Review

MUFG Americas sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 40 shares — an estimated $2K sold.

MUFG Americas first reported a position in HAE in Q2 2013 and held it in 6 quarters. The position peaked at $1.56M in Q2 2013. 172 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

MUFG Americas reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
MUFG Americas sold 40 Haemonetics shares in Q3 2015, an estimated $2K.
MUFG Americas first reported a position in Haemonetics in Q2 2013 and held it in 6 quarters.
MUFG Americas's Haemonetics position peaked at $1.56M in Q2 2013.
172 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on MUFG Americas's 13F filing for Q3 2015, filed 10 Nov 2015.